UP!
 |
|
|
Type
|
Public |
|---|---|
| Traded as | NYSE: HBI S&P 500 Component |
| Founder | John Wesley Hanes - Shamrock Mills, Pleasant H. Hanes - P. H. Hanes Knitting Company |
| Headquarters | Winston-Salem, North Carolina, US |
|
Number of locations
|
252 outlet stores (2015) |
|
Key people
|
Gerald W. Evans Jr. (CEO) |
| Revenue |  US$5.7 billion (2016) |
|
Operating income
|
US$595.1 million (2016) |
|
Net income
|
US$428.8 million (2016) |
| Total assets | US$5.6 billion (2016) |
| Total equity |  US$1.2 billion (2016) |
|
Number of employees
|
65,300 (January 2016) |
| Website | www |
Hanesbrands Inc. is an American clothing company based in Winston-Salem, North Carolina. It employs 65,300 people internationally. On September 6, 2006, the company was spun off by the Sara Lee Corporation.
Hanesbrands owns several clothing brands, including Hanes, Champion, Playtex, Bali, L'eggs, Just My Size, Hanes Hosiery, Barely There, Wonderbra, Duofold, Airé, Beefy-T, C9 by Champion, Cacharel, Celebrity, Daisyfresh, J. E. Morgan, One Hanes Places, Maidenform, Rinbros, Ritmo, Sheer Energy, Silk Reflections, Sol, Sol y Oro, Tagless, and Zorba.
Hanesbrands operates and owns around 250 L'eggs Hanes Bali Playtex Factory Outlets and Hanesbrands Stores across the US. They are a chain of outlet stores that offer discounts. Hanesbrands' flagship store is located in Winston-Salem, North Carolina, and opened in summer 2008. This store is the largest store and offers all of Hanesbrands brands. Hanesbrands has recently started opening Champion Outlet Stores in addition to their Hanesbrands Stores. Currently there are 20 Champion stores open. The original Hanes outlet store was housed in a room adjacent to their factory. It is a true outlet store, where people local to the area could come and buy factory direct, and save the markups associated with retailing. Today, Hanesbrands Inc operates 268 stores across the US under the Hanesbrands, Leggs Hanes Bali Playtex, Maidenform and Champion brands. Stores range in size from 2,500 to 17,000 square feet and have the largest assortment of intimates, including bras, panties, shapewear, comfort and leg wear under one roof in the US.
Hanesbrands has companies in various parts of Europe and Eastern Europe, including the United Kingdom, Italy, Germany, France and Spain.
Sales revenue for 2010 was $4.33 billion and gross profit was $1.41 billion.
Hanesbrands has been recognized for work that it has done for the environment, including "green" buildings. They have also been recognized for the work they have done in communities, such as the support of schools in Honduras.
In 2011, Wikileaks revealed that the corporation had previously lobbied the State Department to prevent the raise of Haiti's minimum-wage to $0.61 an hour from $0.31 an hour.
On July 24, 2013, Hanesbrands agreed to acquire Maidenform for $575 million.
On 15 July 2016 Hanes acquired the Australian-based clothing and underwear and clothing company Pacific Brands
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-09 | 0.29 | 0.29 |
| Q2 2022 | 2022-08-11 | 0.28 | 0.28 |
| Q1 2022 | 2022-05-05 | 0.34 | 0.34 |
| Q4 2021 | 2022-02-03 | 0.44 | 0.44 |
| Q3 2021 | 2021-11-04 | 0.53 | 0.53 |
| Q2 2021 | 2021-08-05 | 0.47 | 0.47 |
| Q1 2021 | 2021-05-11 | 0.39 | 0.39 |
| Q4 2020 | 2021-02-09 | 0.38 | 0.38 |
| Q3 2020 | 2020-11-05 | 0.42 | 0.42 |
| Q2 2020 | 2020-07-30 | 0.60 | 0.60 |
| 2016-07-07 | Reiterated Rating | FBR & Co | Outperform | $39.00 |
| 2016-07-06 | Reiterated Rating | Nomura | Sell | $31.00 |
| 2016-06-14 | Reiterated Rating | Brean Capital | Buy | $37.00 |
| 2016-06-02 | Reiterated Rating | Brean Capital | Buy | $35.00 to $37.00 |
| 2016-06-01 | Reiterated Rating | Morgan Stanley | Buy | |
| 2016-06-01 | Reiterated Rating | Wells Fargo | Buy | |
| 2016-06-01 | Reiterated Rating | Wells Fargo & Co. | Buy | |
| 2016-05-19 | Reiterated Rating | Morgan Stanley | Buy | $34.00 |
| 2016-04-28 | Reiterated Rating | Brean Capital | Buy | |
| 2016-04-23 | Reiterated Rating | FBR & Co. | Buy | $39.00 |
| 2016-04-23 | Reiterated Rating | FBR & Co | Buy | $39.00 |
| 2016-04-22 | Reiterated Rating | Brean Capital | Buy | $33.00 to $35.00 |
| 2016-04-10 | Reiterated Rating | FBR & Co. | Buy | $39.00 |
| 2016-04-09 | Reiterated Rating | Brean Capital | Buy | |
| 2016-04-08 | Lower Price Target | Nomura | Buy | $33.00 to $31.00 |
| 2016-04-08 | Lower Price Target | Nomura Holdings Inc. | Buy | $33.00 to $31.00 |
| 2016-04-06 | Lower Price Target | Cowen and Company | Outperform | $34.00 to $32.00 |
| 2016-04-06 | Reiterated Rating | Wells Fargo | Buy | $33.00 |
| 2016-02-16 | Boost Price Target | Goldman Sachs | Buy | $37.00 to $38.00 |
| 2016-02-16 | Reiterated Rating | Brean Capital | Buy | $33.00 |
| 2016-02-16 | Boost Price Target | Goldman Sachs Group Inc. | Buy | $37.00 to $38.00 |
| 2016-02-14 | Reiterated Rating | FBR & Co. | Outperform | $39.00 |
| 2016-02-08 | Lower Price Target | Citigroup Inc. | $39.00 to $34.00 | |
| 2016-02-06 | Reiterated Rating | Oppenheimer | Buy | |
| 2016-02-06 | Reiterated Rating | Oppenheimer Holdings Inc. | Buy | |
| 2016-02-05 | Reiterated Rating | FBR & Co. | Buy | $39.00 |
| 2016-02-05 | Lower Price Target | Nomura | Buy | $35.00 to $33.00 |
| 2016-02-05 | Lower Price Target | Goldman Sachs | Buy | $41.00 to $37.00 |
| 2016-02-05 | Lower Price Target | Evercore ISI | Buy | $38.00 to $34.00 |
| 2016-02-05 | Lower Price Target | DA Davidson | Neutral | $31.00 |
| 2016-02-05 | Lower Price Target | Credit Suisse | Outperform | $40.00 to $36.00 |
| 2016-02-05 | Lower Price Target | Credit Suisse Group AG | Outperform | $40.00 to $36.00 |
| 2016-02-04 | Reiterated Rating | Brean Capital | Buy | $38.00 to $33.00 |
| 2016-01-21 | Lower Price Target | Goldman Sachs | $42.00 to $41.00 | |
| 2016-01-11 | Upgrade | Northland Securities | Neutral to Buy | |
| 2016-01-11 | Upgrade | Nomura | Neutral to Buy | $30.00 to $35.00 |
| 2015-12-16 | Reiterated Rating | Cowen and Company | Outperform | $38.00 |
| 2015-12-04 | Upgrade | Goldman Sachs | Buy to Conviction-Buy | $42.00 |
| 2015-10-29 | Boost Price Target | Credit Suisse | Outperform | $38.00 to $40.00 |
| 2015-10-29 | Reiterated Rating | Brean Capital | Buy | $36.00 to $38.00 |
| 2015-10-29 | Reiterated Rating | DA Davidson | Hold | $30.00 to $35.00 |
| 2015-10-29 | Lower Price Target | Barclays | Overweight | $38.00 to $35.00 |
| 2015-10-29 | Lower Price Target | Barclays PLC | Overweight | $38.00 to $35.00 |
| 2015-10-26 | Downgrade | DA Davidson | Buy to Neutral | $37.00 to $30.00 |
| 2015-10-22 | Initiated Coverage | Wells Fargo | Outperform | |
| 2015-10-21 | Reiterated Rating | Oppenheimer | Outperform | $35.00 |
| 2015-10-15 | Initiated Coverage | Brean Capital | Buy | $36.00 |
| 2015-10-15 | Initiated Coverage | Oppenheimer | Outperform | $35.00 to $35.00 |
| 2015-09-17 | Upgrade | Goldman Sachs | Neutral to Buy | $32.00 to $40.00 |
| 2015-08-01 | Reiterated Rating | Credit Suisse | Buy | |
| 2015-07-02 | Reiterated Rating | Barclays | Overweight | $38.00 |
| 2015-05-15 | Upgrade | DA Davidson | Neutral to Buy | $37.00 |
| 2015-05-04 | Initiated Coverage | Cowen and Company | Outperform | $38.00 |
| 2015-04-24 | Reiterated Rating | Nomura | Neutral | $27.50 to $30.00 |
| 2015-04-24 | Boost Price Target | Citigroup Inc. | Buy | $37.00 to $39.00 |
| 2015-04-24 | Boost Price Target | Wunderlich | Buy | $32.00 to $40.00 |
| 2015-04-10 | Reiterated Rating | Credit Suisse | Outperform | $38.00 |
| 2015-03-16 | Reiterated Rating | Barclays | Overweight | |
| 2015-03-16 | Initiated Coverage | Sterne Agee CRT | Buy | $38.00 |
| 2015-03-06 | Initiated Coverage | FBR & Co. | Outperform | $34.00 to $37.00 |
| 2015-03-05 | Boost Price Target | Citigroup Inc. | Buy | $35.25 to $37.00 |
| 2015-02-25 | Set Price Target | Wunderlich | Buy | $32.25 |
| 2015-02-20 | Boost Price Target | Barclays | Overweight | $32.50 to $37.50 |
| 2015-01-30 | Boost Price Target | Citigroup Inc. | Buy | $34.75 to $35.25 |
| 2015-01-30 | Boost Price Target | Barclays | Overweight | $30.00 to $32.50 |
| 2015-01-27 | Boost Price Target | Wunderlich | Buy | $31.00 to $32.25 |
| 2015-01-09 | Initiated Coverage | Morgan Stanley | Overweight | $34.50 |
| 2014-11-17 | Reiterated | FBR Capital | Outperform | $120 to $135 |
| 2014-11-17 | Boost Price Target | FBR & Co. | Outperform | $30.00 to $33.75 |
| 2014-10-30 | Reiterated Rating | Citigroup Inc. | Buy | $31.00 to $31.50 |
| 2014-10-30 | Reiterated Rating | Wunderlich | Positive to Neutral | $28.75 to $29.50 |
| 2014-10-02 | Initiated Coverage | Credit Suisse | Focus List to Outperform | $31.25 |
| 2014-09-25 | Boost Price Target | FBR & Co. | Outperform | $28.75 to $30.00 |
| 2014-09-12 | Reiterated Rating | Citigroup Inc. | Buy | $30.25 to $31.00 |
| 2014-09-12 | Initiated Coverage | Wunderlich | Buy | $31.00 |
| 2014-07-25 | Reiterated Rating | Citigroup Inc. | Buy | $28.25 to $30.25 |
| 2014-07-24 | Reiterated Rating | Nomura | Neutral | $21.25 to $27.50 |
| 2014-07-24 | Reiterated Rating | DA Davidson | Neutral | $25.00 to $27.00 |
| 2014-07-24 | Boost Price Target | FBR & Co. | Outperform | $27.75 to $28.75 |
| 2014-07-01 | Reiterated | FBR Capital | Outperform | $100 to $111 |
| 2014-06-30 | Reiterated Rating | Citigroup Inc. | Buy | $21.75 to $28.25 |
| 2014-06-26 | Reiterated Rating | Barclays | Overweight | $22.50 to $28.75 |
| 2014-06-26 | Boost Price Target | DA Davidson | Neutral | $22.25 to $25.00 |
| 2014-06-25 | Upgrade | Brean Capital | Hold to Buy | $27.50 |
| 2014-06-24 | Reiterated | FBR Capital | Outperform | $88 to $100 |
| 2014-06-24 | Boost Price Target | FBR & Co. | Outperform | $22.00 to $25.00 |
| 2014-05-19 | Reiterated | Janney | Buy | $88 to $90 |
| 2014-05-19 | Boost Price Target | Janney Montgomery Scott | Buy | $22.00 to $22.50 |
| 2014-04-28 | Boost Price Target | DA Davidson | Neutral | $19.75 to $20.75 |
| 2014-04-25 | Boost Price Target | Nomura | Neutral | $20.00 to $21.25 |
| 2014-04-25 | Boost Price Target | FBR & Co. | Outperform | $21.00 to $22.00 |
| 2014-04-25 | Boost Price Target | Evercore ISI | $20.00 to $22.50 | |
| 2014-03-03 | Initiated Coverage | Goldman Sachs | Neutral | |
| 2014-02-28 | Initiated Coverage | Nomura | Neutral to Hold | $18.25 |
| 2014-02-28 | Downgrade | Stifel Nicolaus | Buy to Hold | $18.25 |
| 2014-02-18 | Upgrade | Ned Davis Research | Neutral to Buy | |
| 2014-02-12 | Initiated Coverage | Nomura | Neutral | $18.75 |
| 2014-01-30 | Reiterated Rating | Janney Montgomery Scott | Buy | $19.50 |
| 2014-01-28 | Lower Price Target | Janney Montgomery Scott | $20.00 to $18.75 | |
| 2014-01-21 | Downgrade | Ned Davis Research | Buy to Neutral | |
| 2014-01-07 | Boost Price Target | FBR & Co. | Outperform | $18.75 to $21.00 |
| 2013-12-30 | Downgrade | Ned Davis Research | Buy to Neutral | |
| 2013-12-12 | Initiated Coverage | Brean Capital | Hold | |
| 2013-11-01 | Boost Price Target | DA Davidson | Neutral | $17.00 to $18.50 |
| 2013-10-31 | Boost Price Target | Evercore ISI | Buy | $17.50 to $20.00 |
| 2013-10-31 | Boost Price Target | BB&T Corp. | Buy | $17.25 to $18.25 |
| 2013-10-31 | Boost Price Target | Barclays | Overweight | $17.50 to $21.25 |
| 2013-10-31 | Reiterated Rating | Janney Montgomery Scott | Buy | |
| 2013-10-31 | Boost Price Target | FBR & Co. | Outperform | $16.75 to $18.25 |
| 2013-10-15 | Initiated Coverage | Goldman Sachs | Neutral | |
| 2013-09-24 | Downgrade | DA Davidson | Buy to Neutral | $17.00 |
| 2013-04-05 | Reiterated | Janney | Buy | $50 to $52 |
| 2011-06-09 | Downgrade | Barclays Capital | Overweight to Equal Weight | $35 to $30 |
| 2011-04-21 | Reiterated | FBR Capital | Outperform | $31 to $36 |
| 2011-01-28 | Reiterated | Brean Murray | Buy | $35 to $40 |
| 2010-08-10 | Reiterated | Brean Murray | Buy | $33 to $35 |
| 2016-07-07 | Reiterated Rating | FBR & Co | Outperform | $39.00 |
| 2016-07-06 | Reiterated Rating | Nomura | Sell | $31.00 |
| 2016-06-14 | Reiterated Rating | Brean Capital | Buy | $37.00 |
| 2016-06-02 | Reiterated Rating | Brean Capital | Buy | $35.00 to $37.00 |
| 2016-06-01 | Reiterated Rating | Morgan Stanley | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In HBI 398 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 37.71M |
| Vanguard Group, Inc | 34.29M |
| COOKE & BIELER LP | 20.69M |
| SHAPIRO CAPITAL MANAGEMENT LLC | 13.95M |
| FULLER & THALER ASSET MANAGEMENT, INC. | 12.32M |
| BlackRock Institutional Trust Company, N.A. | 9.99M |
| LYRICAL ASSET MANAGEMENT LP | 9.86M |
| STATE STREET CORP | 9.62M |
| PARNASSUS INVESTMENTS /CA | 7.51M |
| MORGAN STANLEY | 6.71M |
| Standard Life Investments LTD | 6.62M |
| BlackRock Fund Advisors | 6.48M |
| DIAMOND HILL CAPITAL MANAGEMENT INC | 6.35M |
| NEW SOUTH CAPITAL MANAGEMENT INC | 5.64M |
| LSV ASSET MANAGEMENT | 5.10M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Evans Gerald Chief Operating Officer | 1.19% (1180706) | HBI / |
| NOLL RICHARD A Chairman and CEO | 0.82% (814103) | HBI / TFM / |
| Upchurch W Howard Jr President, Innerwear | 0.46% (461423) | HBI / |
| Faircloth Michael E. Pres., Chief Global Ops Offcr | 0.26% (261355) | HBI / |
| MOSS RICHARD D Chief Financial Officer | 0.24% (236015) | HBI / WGO / |
| Nictakis William J CCO Intl Bus Global Retailer | 0.16% (159649) | HBI / |
| Mathews Jessica Tuchman | 0.13% (134244) | HBI / |
| JOHNSON JOIA M Chief Legal Ofcr, GC&Corp Sec | 0.12% (124325) | HBI / RARE / |
| Marsh John T. President, Activewear | 0.12% (122924) | HBI / |
| NELSON RONALD L | 0.11% (106683) | CAR / CVG / HBI / VIAB / |
| Burger Elizabeth Chief Human Resources Officer | 0.11% (105778) | FLS / HBI / |
| Hytinen Barry Chief Financial Officer | 0.07% (71977) | HBI / TPX / |
| Oliver Kevin Chief Human Resources Officer | 0.06% (59754) | HBI / |
| MULCAHY J PATRICK | 0.04% (44200) | ENR / HBI / |
| Lewis Markland Scott Chief Accounting Officer | 0.03% (29807) | HBI / |
| MOISON FRANCK J | 0.02% (18936) | CL / HBI / UPS / |
| SINGER DAVID V | 0.02% (16880) | BC / COKE / FLO / HBI / LNCE / SPW / |
| MORAN ROBERT F | 0.02% (15743) | GNC / HBI / |
| SCHINDLER ANDREW J | 0.02% (14970) | CAG / HBI / KKD / |
| Ryan Michael S. Controller and CAO | 0.01% (14584) | HBI / |
| ZIEGLER ANN ELIZABETH | 0.01% (7983) | CDW / GRPN / HBI / |
| Johnson James C | 0.01% (6683) | AEE / ENR / HBI / |
| GRIFFIN BOBBY J | 0.01% (6683) | AAWW / HBI / URI / WCC / |
| CHADEN LEE A | 0.01% (6244) | HBI / RRD / |
UM